difelikefalin sold brand name korsuva opioid peptide used treatment moderate severe itch acts peripherallyrestricted highly selective agonist Îºopioid receptor difelikefalin acts analgesic activating kors peripheral nerve terminals kors expressed certain immune system activation kors peripheral nerve terminals results inhibition ion channels responsible afferent nerve activity causing reduced transmission pain signals activation kors expressed immune system cells results reduced release proinflammatory nervesensitizing mediators eg difelikefalin approved medical use united states august us food drug administration considers firstinclass february committee medicinal products human use chmp european medicines agency adopted positive opinion recommending granting marketing authorization medicinal product kapruvia intended treatment moderatetosevere pruritus associated chronic kidney applicant medicinal product vifor fresenius medical care renal pharma difelikefalin approved medical use european union april development cara therapeutics intravenous agent treatment postoperative oral formulation also due peripheral selectivity difelikefalin lacks central side effects like sedation dysphoria hallucinations previous koracting analgesics pentazocine addition use analgesic difelikefalin also investigated treatment pruritus difelikefalin completed phase ii clinical trials postoperative pain demonstrated significant robust clinical efficacy along safe well also completed phase iii clinical trial uremic pruritus hemodialysis analgesicrelated article stub help wikipedia expanding httpsenwikipediaorgwikidifelikefalin